Suppr超能文献

利用孟德尔随机化分析剖析欧洲和东亚人群肠道微生物群与肝癌之间的关联。

Dissecting the association between gut microbiota and liver cancer in European and East Asian populations using Mendelian randomization analysis.

作者信息

Jiang Hua, Song Tianjun, Li Zhongyi, An Lingxuan, He Chiyi, Zheng Kai

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Wannan Medical College, Wuhu City, China.

Department of Medicine II, University Hospital, Munich, Germany.

出版信息

Front Microbiol. 2023 Sep 18;14:1255650. doi: 10.3389/fmicb.2023.1255650. eCollection 2023.

Abstract

BACKGROUND

Ample evidence suggests an important role of the gut microbiome in liver cancer, but the causal relationship between gut microbiome and liver cancer is unclear. This study employed Mendelian randomization (MR) analysis to examine the causal relationship between the gut microbiome and liver cancer in European and East Asian populations.

METHODS

We sourced genetic variants linked to gut microbiota from the MiBioGen consortium meta-analysis, and procured liver cancer genome-wide association study (GWAS) summary data from the FinnGen consortium and Biobank Japan. We employed the inverse variance weighted method for primary statistical analysis, fortified by several sensitivity analyses such as MR-PRESSO, MR-Egger regression, weighted median, weighted mode, and maximum likelihood methods for rigorous results. We also evaluated heterogeneity and horizontal pleiotropy.

RESULTS

The study examined an extensive set of gut microbiota, including 131 genera, 35 families, 20 orders, 16 classes, and 9 phyla. In Europeans, ten gut microbiota types displayed a suggestive association with liver cancer ( < 0.05). Notably, and exhibited a statistically significant positive association with liver cancer risk, with odds ratios (OR) of 2.59 (95% CI 1.36-4.95) and 2.03 (95% CI 1.21-3.40), respectively, after adjusting for multiple testing. In East Asians, while six microbial types demonstrated suggestive associations with liver cancer, only displayed a statistically significant positive association (OR = 1.56, 95% CI 1.11-2.19) with an FDR < 0.05. Sensitivity analyses reinforced these findings despite variations in -values.

CONCLUSION

This study provides evidence for a causal relationship between specific gut microbiota and liver cancer, enhancing the understanding of the role of the gut microbiome in liver cancer and may offer new avenues for preventive and therapeutic strategies.

摘要

背景

大量证据表明肠道微生物群在肝癌中起重要作用,但肠道微生物群与肝癌之间的因果关系尚不清楚。本研究采用孟德尔随机化(MR)分析来检验欧洲和东亚人群中肠道微生物群与肝癌之间的因果关系。

方法

我们从MiBioGen联盟的荟萃分析中获取了与肠道微生物群相关的基因变异,并从芬兰基因组联盟和日本生物银行获得了肝癌全基因组关联研究(GWAS)汇总数据。我们采用逆方差加权法进行主要统计分析,并通过多种敏感性分析(如MR-PRESSO、MR-Egger回归、加权中位数、加权模式和最大似然法)来确保结果的严谨性。我们还评估了异质性和水平多效性。

结果

该研究检测了大量的肠道微生物群,包括131个属、35个科、20个目、16个纲和9个门。在欧洲人中,十种肠道微生物类型与肝癌存在潜在关联(<0.05)。值得注意的是,在进行多重检验校正后,[具体微生物1]和[具体微生物2]与肝癌风险呈统计学显著正相关,比值比(OR)分别为2.59(95%CI 1.36 - 4.95)和2.03(95%CI 1.21 - 3.40)。在东亚人中,虽然六种微生物类型与肝癌存在潜在关联,但只有[具体微生物3]与肝癌呈统计学显著正相关(OR = 1.56,95%CI 1.11 - 2.19),错误发现率(FDR)<0.05。尽管P值有所变化,但敏感性分析强化了这些发现。

结论

本研究为特定肠道微生物群与肝癌之间的因果关系提供了证据,加深了对肠道微生物群在肝癌中作用的理解,并可能为预防和治疗策略提供新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5c/10544983/518a01a7d18e/fmicb-14-1255650-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验